Monday, May 25, 2015Monday, May 25, 2015

US frees up another experimental Ebola drug

Published on Aug 8, 2014 6:06 AM

WASHINGTON (AFP) - US regulators loosened restrictions on a new experimental drug for treating Ebola, which may allow it to be tried on infected patients in West Africa, the company said on Thursday.

The Canada-based company, Tekmira, said the US Food and Drug Administration changed the classification of its drug TKM-Ebola from full clinical hold to partial hold.

"This action enables the potential use of TKM-Ebola in individuals infected with Ebola virus," said a company statement.

Tests on monkeys have shown the drug provided 100 per cent protection from an otherwise lethal dose of Ebola, the company said.

Enjoy 2 weeks of unlimited digital access to The Straits Times. Get your free access now!